// App-Quantinova.ai

2778 : Preventing Rheumatoid Arthritis: North American Perspectives of Patients and First-Degree Relatives on the Risk of Developing the Disease and of Potential Preventative Interventions

Researchers

Presenter

  • Mark Harrison

Principal Investigators

  • Luke Spooner

  • Marie Hudson

  • Katherine Milbers

  • Cheryl L. Koehn

  • Axel Finckh

  • Nick Bansback

Medical Centers

  • Pharm Sciences, Univ of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada

  • Center forHealth Evaluation and Outcomes Sciences, Vancouver, BC, Canada

  • Arthritis Consumer Experts, Vancouver, BC, Canada

  • University Hospital Geneva, Geneva, Switzerland

  • School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • 3β-hydroxysterol Δ24-reductase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A